Multidisciplinary Perioperative Care Pathway in Adolescents Undergoing Posterior Spinal Fusion Surgery

May 12, 2023 updated by: Davina Wildemeersch, University Hospital, Antwerp

Biopsychosocial Model for a Multidisciplinary Perioperative Care Pathway in Patients Undergoing Posterior Spinal Fusion Surgery for Adolescent Idiopathic Scoliosis

Posterior Spinal fusion (PSF) is one of the most invasive orthopedic surgical procedures in children and adolescents, often characterized by extensive tissue trauma, and severe postoperative pain. In addition to pain, the postoperative period is complicated by the side effects of opioids such as nausea and vomiting, itching and sedation. Various studies have shown that pain in the direct postoperative phase is an important determinant for development of chronic post-surgical pain.

The consequences of untreated acute pain are known and can also contribute to chronification in pain.

Study Overview

Detailed Description

Surgical correction of adolescent idiopathic scoliosis (AIS) is indicated for severe deformity. Posterior Spinal fusion (PSF) for AIS is one of the most invasive orthopedic surgical procedures in children and adolescents, often characterized by a large surgical incision, extensive tissue trauma, risk of blood loss, longer operating times and severe postoperative pain. In addition to pain, the postoperative period is complicated by the side effects of opioids such as nausea and vomiting, itching and sedation. All of this can, along with under-treatment of postoperative pain, be an important delaying factor in postoperative recovery and rehabilitation with a late hospital discharge and increased patient dissatisfaction. Various studies have shown that pain in the direct postoperative phase is an important determinant for development of chronic post-surgical pain.

The consequences of untreated pain are known and can also contribute to chronification in pain.

The incidence of chronic post-surgical pain after scoliosis fusion is 22% at 6 months and 11-15% at 1 to 5 years postoperatively. It is therefore important to minimize the pain during the first postoperative days. Untreated pain in patients is far from benign with significant negative short and long term consequences with accompanying reduction in rehabilitation duration, sleep quality of life. To date, there is no scientific evidence that some analgesic policy is superior, making adequate and safe pain relief and associated anti-emetic therapy after PSF a challenge makes for all healthcare providers involved.

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Antwerp
      • Edegem, Antwerp, Belgium, 2650
        • University Hospital Antwerp

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • approved written informed consent by parent or legal representative
  • idiopathic adolescent scoliosis
  • planned for elective surgery: posterior spinal fusion

Exclusion Criteria:

  • other types of scoliosis
  • chronic opioid usage (more than 3 months)
  • known unstable psychiatric medical condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of care
Prospective derived data from children and adolescents undergoing spinal fusion due to idiopathic scoliosis
Experimental: Enhanced recovery pathway
Children and adolescents undergoing spinal fusion due to idiopathic scoliosis using the pre -per and postoperative enhanced recovery protocol
The applied protocol include psychological screening for yellow flags, preoperative gabapentin, peroperative multimodal preemptive management and postoperative holistic evaluation short -and long term

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative pain
Time Frame: From admission postoperative anesthesia care unit (PACU) up to 3 months postoperatively
Evaluation of pain at rest and during mobilization using 11 point numeric rating scale daily during hospital admission and is continued after discharge up to 3 months postoperatively
From admission postoperative anesthesia care unit (PACU) up to 3 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluation of opioid-related side effect
Time Frame: From admission postoperative anesthesia care unit (PACU) up to 3 months after surgery
Evaluation of opioid-related side effect as nausea, vomiting and pruritus
From admission postoperative anesthesia care unit (PACU) up to 3 months after surgery
sleep
Time Frame: From admission postoperative anesthesia care unit (PACU) up to 3 months after surgery
Subjective sleep score using 11 point numeric rating scale
From admission postoperative anesthesia care unit (PACU) up to 3 months after surgery
daily activity
Time Frame: From admission postoperative anesthesia care unit (PACU) up to 3 months after surgery
Subjective activity score using 11 point numeric rating scale
From admission postoperative anesthesia care unit (PACU) up to 3 months after surgery
mobility
Time Frame: From day of surgery until hospital discharge (approximately 7 days)
Daily mobility assessment by attending physiotherapist on 4 point scale
From day of surgery until hospital discharge (approximately 7 days)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
State-Trait anxiety Inventory (STAI)
Time Frame: 3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
evaluation of state and trait characteristics by the STAI questionnaire, via a patient specific online platform
3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
Multidimensional Pain Inventory (MPI, Part 1)
Time Frame: 3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
Screening for pain and psychosocial aspects
3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
Child and Adolescent Social and Adaptive Scale (CASAFS)
Time Frame: 3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
Screening for pain and psychosocial aspects
3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
Childhood Depression Inventory (CDI-2)
Time Frame: 3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
screening for depression
3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
Pain Response Inventory (PRI)
Time Frame: 3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery
screening for pain coping
3 times: one to two weeks before planned surgery, 4 weeks after surgery and at 12 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Guy Hans, MD, PhD, University Hospital, Antwerp

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2019

Primary Completion (Actual)

November 3, 2021

Study Completion (Actual)

January 1, 2022

Study Registration Dates

First Submitted

July 26, 2019

First Submitted That Met QC Criteria

July 26, 2019

First Posted (Actual)

July 30, 2019

Study Record Updates

Last Update Posted (Actual)

May 15, 2023

Last Update Submitted That Met QC Criteria

May 12, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Enhanced recovery pathway

Subscribe